Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$3.7 - $8.6 $66,881 - $155,453
-18,076 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$5.55 - $18.46 $100,321 - $333,682
18,076 New
18,076 $101,000

Others Institutions Holding VAXX

About Vaxxinity, Inc.


  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.